Filipino FDA warns about fake drugs

GC, MDGC

Filipino FDA warns about fake drugs

24 Nov, 2011

Published over 14 years ago. See the latest and most current information on GC, MDGC.

The Food and Drug Administration (FDA) has warned the public of the Philippines to be on their guard against counterfeit medicines.

FDA director Dr Suzette Lazo said that consumers in the country should be careful about buying cheaper drugs, as many unscrupulous traders are reducing the content in capsules to produce more for the same cost.

Dr Lazo also warned that the fake drugs, which can be checked through mass chromatography processes, could be dangerous as they have the potential to aggravate a patient's health problems, cause a failure of treatment or even be fatal.

She explained that the issue had emerged as a result of the public's demand for cheaper medicines.

Signs to look out for are suspiciously low price, unusual packaging and irregularly colouring of the pills themselves.

The FDA added that it will continue to monitor the situation and check suspect drugs through laboratory-based chromatography testing.

Posted by Ben Evans

Explore Our Other Sites

Labmate Online
Green analytical chemistry review calls for integrated sustainability metrics and AI to improve pharmaceutical analysis
Explore more Arrow
Envirotech Online
England's rivers and lakes: what the 2025 data really shows about pollution drivers
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
EU E20 plans could create a new testing workload for fuel laboratories
Explore more Arrow